Patents/Assignees

ALX Oncology Inc.

8 patents in portfolio

US12527838utility2026
Combination Therapies Comprising an Agent That Blocks the Interaction Between CD47 and Sirpα for Treating Gastric or Gastroesphageal Junction Cancel
0 cites
US12404340utility2025
Antibodies Against Signal-regulatory Protein Alpha and Methods of Use
0 cites
US12343377utility2025
Combination Therapies Comprising a Hypomethylation Agent for Treating Cancer
0 cites
US12098214utility2024
Combination Therapies for Treating Cancer
0 cites
US11939393utility2024
Antibodies Against Signal-regulatory Protein Alpha and Methods of Use
0 cites
US11939385utility2024
Activatable Antibodies and Methods of Use Thereof
0 cites
US11639376utility2023
Constructs Having a Sirp-α Domain or Variant Thereof
0 cites
US11613564utility2023
Methods of Treating Cancer
0 cites